• AAPL 195.71
  • TSLA 243.84
  • AMZN 147.42
  • BTC-USD 43962.707
  • ETH-USD 2352.6274
  • EURUSD 1.0764
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. ENDPQ.US

Endo International plc (ENDPQ OTCMKTS) stock market data APIs

$0.002 0(0%) as of December 8, 2023

Endo International plc Financial Data Overview

0.002
0.002
-
0.002
0.002
0.0009-0.14
470 K
235 M
2 070 M
0.56
0.0242
1.115
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ENDPQ',
Type: 'Common Stock',
Name: 'Endo International plc',
Exchange: 'OTCMKTS',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000C0HQ54',
ISIN: 'IE00BJ3V9050',
CUSIP: NULL,
CIK: '0001593034',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
GicSector: NULL,
GicGroup: NULL,
GicIndustry: NULL,
GicSubIndustry: NULL,
HomeCategory: NULL,
IsDelisted: false,
}

Endo International plc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 070 M
  • EBITDA 180 M
  • Earnings Per Share -1.07
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Endo International plc Earnings via APIs

  • Latest Release 2023-11-06
  • EPS/Forecast 0.351

Get Endo International plc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Endo International plc latest news via APIs

Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis

DUBLIN, March 13, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today announced top-line results from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in participants with...
  • CLINICAL STUDY
  • ENDO INTERNATIONAL
  • PHASE 2 STUDY
  • PLANTAR FIBROMATOSIS
  • SCALE SCORE

McKinsey Consulted VA While Advising Opioid Makers to Target Agency for Sales

Since at least 2009, McKinsey has been a consultant to the U.S. Department of Veterans Affairs. During part of that time, the consulting giant also advised some of the world’s biggest opioid produce...
  • DEPARTMENT OF VETERANS AFFAIRS
  • MCKINSEY
  • PURDUE PHARMA
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com